SCHEMBL18308788

SCHEMBL18308788

Cc1ccc(-c2cccc(-c3ccc(P)cc3)c2)c(C)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 1/20 0.41
▸ MAPT P10636 4/20 0.40
▸ ESR2 Q92731 2/20 0.39
▸ ESR1 P03372 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.37
▸ FFAR1 O14842 1/20 0.37
▸ ENPP3 O14638 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ HSD17B1 P14061 1/20 0.35
▸ HSD17B2 P37059 1/20 0.35
▸ CNR1 P21554 1/20 0.35
▸ CNR2 P34972 1/20 0.35
▸ DHODH Q02127 1/20 0.35
▸ ALKBH3 Q96Q83 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18308803 0.90 MAPT (0.40) PGRMAPTESR2ESR1ALDH1A1
SCHEMBL18308794 0.89 MAPT (0.39) PGRMAPTESR2ESR1FFAR1
SCHEMBL18308787 0.87 ESR2 (0.40) PGRMAPTESR2ESR1ALDH1A1
SCHEMBL18308741 0.85 ESR2 (0.41) MAPTESR2ESR1ALDH1A1MEN1
SCHEMBL30196173 0.85 ESR2 (0.47) MAPTESR2ESR1FFAR1MEN1
SCHEMBL18308790 0.85 ESR2 (0.38) PGRMAPTESR2ESR1FFAR1
SCHEMBL18621839 0.83 DHODH (0.45) PGRMAPTESR1ALDH1A1MEN1
SCHEMBL18621843 0.82 PGR (0.38) PGRMAPTESR1ALDH1A1ENPP3
SCHEMBL18308778 0.82 HTR7 (0.36) PGRMAPTESR2ESR1FFAR1
SCHEMBL18308786 0.82 ESR2 (0.37) PGRMAPTESR2ESR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11718791-B2 Polymerisable compounds and the use thereof in liquid-crystal displays MERCK PATENT GMBH (DE) 2023-08-08 — — US disclosed
US-20170121606-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS GMBH, MERCK PATENT (DE) 2017-05-04 — — US disclosed
US-20160362606-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS MERCK PATENT GMBH (DE) 2016-12-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11718791-B2 Polymerisable compounds and the use thereof in liquid-crystal displays VCL, ILK, LCP1 PGR 3715/4885MAPT 34/4885ESR2 4146/4885
US-20170121606-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS VCL, LCP1, MAP1LC3C PGR 3826/4885MAPT 41/4885ESR2 4322/4885
US-20160362606-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS VCL, PLEC, EML4 PGR 3596/4885MAPT 40/4885ESR2 4381/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback